Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-drma
/
Dermata Therapeutics Inc
DRMA
6.840
USD
+0.390
+6.05%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
41.26M
Market Cap
Loss
P/E TTM
Dermata Therapeutics Inc
6.840
+0.390
+6.05%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Operating expenses
-26.96%
2.34M
44.17%
3.20M
78.02%
3.23M
66.46%
2.88M
40.65%
3.20M
29.69%
2.22M
-25.92%
1.81M
-36.55%
1.73M
-18.25%
2.28M
-32.95%
1.71M
42.86%
2.45M
105.31%
2.73M
23.18%
2.79M
419.48%
2.55M
217.05%
1.71M
67.76%
1.33M
67.72%
2.26M
--
491.43K
--
540.06K
--
792.79K
--
1.35M
R&D expenses
-19.97%
1.28M
93.13%
2.19M
165.94%
2.40M
139.48%
2.01M
34.22%
1.60M
27.65%
1.14M
-41.87%
902.98K
-47.97%
838.93K
-25.27%
1.19M
-20.01%
889.36K
94.22%
1.55M
85.95%
1.61M
134.48%
1.60M
872.69%
1.11M
563.90%
799.78K
110.51%
867.20K
-29.19%
680.59K
--
114.30K
--
120.47K
--
411.95K
--
961.10K
Depreciation, depletion, and amortization
--
0.00
--
--
--
--
--
0.00
--
0.00
--
--
--
--
--
--
--
0.00
--
--
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
-100.00%
0.00
--
0.00
--
0.00
--
0.00
--
322.00
Operating profit
26.96%
-2.34M
-44.17%
-3.20M
-78.02%
-3.23M
-66.46%
-2.88M
-40.65%
-3.20M
-29.69%
-2.22M
25.92%
-1.81M
36.55%
-1.73M
18.25%
-2.28M
32.95%
-1.71M
-42.86%
-2.45M
-105.31%
-2.73M
-23.18%
-2.79M
-419.48%
-2.55M
-217.05%
-1.71M
-67.76%
-1.33M
-67.72%
-2.26M
--
-491.43K
--
-540.06K
--
-792.79K
--
-1.35M
Net non-operating interest income (expenses)
Non-operating interest expense
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-98.86%
651.00
-93.68%
1.82K
-40.58%
43.13K
--
38.48K
--
57.33K
--
28.86K
--
72.60K
Special income (expenses)
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-100.00%
0.00
--
--
--
--
--
--
--
133.59K
--
--
--
--
--
--
Income before tax
26.50%
-2.30M
-47.66%
-3.15M
-84.57%
-3.17M
-66.28%
-2.83M
-39.91%
-3.13M
-27.81%
-2.13M
29.09%
-1.72M
37.69%
-1.70M
19.60%
-2.24M
34.60%
-1.67M
-41.55%
-2.42M
-105.03%
-2.73M
-20.88%
-2.79M
-544.15%
-2.55M
-186.73%
-1.71M
-62.09%
-1.33M
-62.18%
-2.30M
--
-396.31K
--
-597.39K
--
-821.65K
--
-1.42M
Income after tax
26.50%
-2.30M
-47.66%
-3.15M
-84.57%
-3.17M
-66.28%
-2.83M
-39.91%
-3.13M
-27.81%
-2.13M
29.09%
-1.72M
37.69%
-1.70M
19.60%
-2.24M
34.60%
-1.67M
-41.55%
-2.42M
-105.03%
-2.73M
-20.88%
-2.79M
-544.15%
-2.55M
-186.73%
-1.71M
-62.09%
-1.33M
-62.18%
-2.30M
--
-396.31K
--
-597.39K
--
-821.65K
--
-1.42M
Net income from continuous operations
26.50%
-2.30M
-47.66%
-3.15M
-84.57%
-3.17M
-66.28%
-2.83M
-39.91%
-3.13M
-27.81%
-2.13M
29.09%
-1.72M
37.69%
-1.70M
19.60%
-2.24M
34.60%
-1.67M
-41.55%
-2.42M
-105.03%
-2.73M
-20.88%
-2.79M
-544.15%
-2.55M
-186.73%
-1.71M
-62.09%
-1.33M
-62.18%
-2.30M
--
-396.31K
--
-597.39K
--
-821.65K
--
-1.42M
Net income attributable to controlling interests
26.50%
-2.30M
-47.66%
-3.15M
-84.57%
-3.17M
-66.28%
-2.83M
-39.91%
-3.13M
-27.81%
-2.13M
29.09%
-1.72M
37.69%
-1.70M
19.60%
-2.24M
67.36%
-1.67M
43.29%
-2.42M
-105.03%
-2.73M
-20.88%
-2.79M
-1190.67%
-5.12M
-615.63%
-4.28M
-62.09%
-1.33M
-62.18%
-2.30M
--
-396.31K
--
-597.39K
--
-821.65K
--
-1.42M
Preferred share dividend
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2.56M
--
2.56M
--
--
--
--
--
--
--
--
--
--
--
--
Net income attributable to common shareholders
26.50%
-2.30M
-47.66%
-3.15M
-84.57%
-3.17M
-66.28%
-2.83M
-39.91%
-3.13M
-27.81%
-2.13M
29.09%
-1.72M
37.69%
-1.70M
19.60%
-2.24M
67.36%
-1.67M
43.29%
-2.42M
-105.03%
-2.73M
-20.88%
-2.79M
-1190.67%
-5.12M
-615.63%
-4.28M
-62.09%
-1.33M
-62.18%
-2.30M
--
-396.31K
--
-597.39K
--
-821.65K
--
-1.42M
Basic earnings per share
93.67%
-0.45
69.15%
-2.06
74.76%
-2.04
55.68%
-4.18
79.29%
-7.06
79.44%
-6.68
82.94%
-8.09
83.88%
-9.43
57.42%
-34.08
77.96%
-32.48
76.99%
-47.40
-52.53%
-58.54
-20.53%
-80.06
-1190.79%
-147.40
-1096.72%
-206.02
-62.10%
-38.38
-62.18%
-66.42
--
-11.42
--
-17.22
--
-23.68
--
-40.95
Diluted earnings per share
93.67%
-0.45
69.15%
-2.06
74.76%
-2.04
55.68%
-4.18
79.29%
-7.06
79.44%
-6.68
82.94%
-8.09
83.88%
-9.43
57.42%
-34.08
77.96%
-32.48
76.99%
-47.40
-52.53%
-58.54
-20.53%
-80.06
-1190.79%
-147.40
-1096.72%
-206.02
-62.10%
-38.38
-62.18%
-66.42
--
-11.42
--
-17.22
--
-23.68
--
-40.95
Dividend per share
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up